Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06189820
PHASE2
Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases
Sponsor: Erasme University Hospital
View on ClinicalTrials.gov
Summary
To evaluate the effect of an anti-fibrotic treatment initiation on the fibrotic activity as assessed by FAPI PET/CT.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2023-03-09
Completion Date
2027-03-09
Last Updated
2024-01-05
Healthy Volunteers
No
Interventions
DIAGNOSTIC_TEST
FAPI PET/CT
In the department of Nuclear Medicine: * Installation in a relax chair after weight and height control * Placement of a venous line in the upper limb after which an infusion of 500ml of 0.9% NaCl is started. * Intravenous injection of 3 MBq/kg (max 300 MBq) of 18F- FAPI 74 or of 2 MBq/kg 68Ga-FAPI46
Locations (1)
Medecine
Brussels, Belgium